For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 4,618 | |||
| General and administrative | 4,602 | |||
| Total operating expenses | 9,220 | |||
| Operating loss | -9,220 | |||
| Interest income, net | 520 | |||
| Other income, net | 2 | |||
| Net loss | -8,698 | |||
| Basic EPS | -1.45 | |||
| Basic Average Shares | 5,984,017 | |||
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)